Multiple pathways of type 1 interferon production in lupus: the case for amlexanox

Rheumatology (Oxford). 2020 Dec 1;59(12):3980-3982. doi: 10.1093/rheumatology/keaa469.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • A549 Cells
  • Aminopyridines / therapeutic use*
  • Animals
  • Humans
  • Interferon Type I / antagonists & inhibitors
  • Interferon Type I / biosynthesis*
  • Lupus Erythematosus, Systemic / drug therapy*
  • Lupus Erythematosus, Systemic / metabolism
  • Metabolic Networks and Pathways / drug effects

Substances

  • Aminopyridines
  • Interferon Type I
  • amlexanox